Picture of OncoTherapy Science logo

4564 OncoTherapy Science News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Table: OncoTherapy Science -2020/21 parent results

May 7 (Reuters)- 
          OncoTherapy Science Inc 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Mar 31, 2021    Mar 31, 2020   Mar 31, 2022     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          111 mln         114 mln                               
               (-2.7 pct)      (-44.3 pct)                             
  Operating     loss 1.37       loss 1.82                              
  Recurring     loss 1.34       loss 1.79                              
  Net           loss 1.55       loss 1.98                              
  EPS         loss 8.77 yen  loss 12.13 yen                            
  Ann Div          NIL             NIL            NIL                  
  -Q4 Div          NIL             NIL            NIL                  
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T

Recent news on OncoTherapy Science

See all news